Holland & Knight Health Dose: May 23, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • This Week: June 1, 2023 Debt Limit Deadline Creeps Closer
  • House Energy and Commerce Subcommittee Advances Healthcare Bills for Full Committee Consideration
  • Senate HELP Chairman to Propose Health Care Package
  • House Appropriations Committee Postpones Consideration of FDA Funding Bill
  • House Lawmakers Reintroduce the Telemental Health Services Act
  • Delaware Senator to Retire at the End of Current Term
  • ARPA-H Announces Inaugural Program Targeting Bone Regrowth
  • GAO Releases New Report on Noncompete Agreements
  • FTC Aims to Broaden Regulation of Health Data Privacy Online

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More